Category Archives: Oncology

Exclusive: Why the COVID “mRNA” vaccines are actually DNA gene therapies that must be removed from the market

The transcript is found here May 19, 2023- by Steven E. Greer, MD

Posted in - Biotech, - Opinion, - Pharma, CDC, Congress, FDA, Genetics, Infectious disease, NIH, Oncology | 9 Comments

Interview with Hélène Banoun about why mRNA “vaccines” should be regulated as gene therapies

July 12, 2023- by Steven E. Greer, MD

Posted in - Biotech, - Opinion, - Pharma, - Policy, Cardiology, CDC, Congress, FDA, Infectious disease, Internal Medicine, Oncology | Leave a comment

Steven E. Greer MD: A discussion with Bill O’Reilly about radiation risks

April 1, 2011- A discussion with Bill O’Reilly about radiation risks from the Fukushima nuclear meltdowns and the fallout hitting the U.S. and entire globe.

Posted in - Policy, Congress, NYU, Ohio State, Oncology | Leave a comment

The Who’s Teen Cancer Lounge at Sloan Kettering opens

March 18, 2016- by Steven E. Greer MD The Memorial Sloan Kettering Cancer Center held a press day for its new teen lounge

Posted in Memorial Sloan-Kettering, Oncology | Leave a comment

Book: The Pfizer/Moderna mRNA Vaccine (i.e., gene therapy) Toxicity

September 1, 2023- by Sucharit Bhakdi, MD et al

Posted in - Biotech, - Pharma, - Reviews, books, devices, Cardiology, CDC, Congress, FDA, Infectious disease, Internal Medicine, Neurology, NIH, Oncology, Pediatrics | Leave a comment

Did the COVID vaccines change the human genome?

May 11, 2023- by Steven E. Greer, MD I was the first person on any large media platform to warn that the COVID vaccines would be hard to sell because they worked by altering our genes. I said this on … Continue reading

Posted in - Biotech, - Opinion, - Pharma, - Policy, Cardiology, CDC, FDA, Infectious disease, Internal Medicine, Neurology, NIH, Oncology | Leave a comment

Daily aspirin once again proves to be of no use and also deadly

Update January 13, 2015- Yet another study was published highlighting the risks of daily aspirin. 

Posted in - JAMA, - Pharma, - Policy, Cardiac surgery, Cardiology, Gastroenterology and liver, General surgery, Neurology, Neurosurgery, Oncology, Primary care medicine | Leave a comment

The Daltrey Townshend teenage and young adult cancer center at UCLA

May 4, 2014- Interviewed by Steven E. Greer More than 20 years ago, Roger Daltrey began forming special cancer units in the UK to treat patients in their teenage

Posted in - Opinion, Oncology, Rehab, UCLA | Leave a comment

Crystalloid “Balanced Lactated Ringer’s” IV solution is safer to the kidneys

March 1, 2018- Interviewed by Steven E. Greer, MD We interviewed Vanderbilt’s Todd Rice, MD about his NEJM papers that showed crystalloid, or

Posted in - NEJM, Cardiac surgery, Cardiology, Emergency medicine, General surgery, Internal Medicine, Neurology, Neurosurgery, Obstetrics and Gynecology, Oncology, Orthopedic surgery, Pediatrics, Plastic surgery, Sports medicine, Trauma Surgery, Urology, Vanderbilt, Vascular Surgery | Leave a comment

Interview with Simon Townshend about the Daltrey/Townshend Teen Cancer Program

The Daltrey Townshend teenage and young adult cancer center at UCLA

Posted in Oncology, UCLA | Leave a comment

The new CDC guidelines for prescribing opioid pain pills

June 1, 2016- Interviewed by Steven E. Greer, MD Pain pill prescriptions have quadrupled since the 1990’s as drug companies stepped up marketing and funded

Posted in - JAMA, - NEJM, - Pharma, CDC, Emergency medicine, General surgery, Oncology, Psychology Psychiatry, Rehab, Spine surgery, Sports medicine | Leave a comment

How human behavior has changed since 1950

January 26, 2020- by Seven E. Greer, MD What defines the generations? What fundamentally changed the way we behave?

Posted in - Opinion, - Policy, Bariatric surgery, Cardiac surgery, Cardiology, Diabetes and endocrinology, Genetics, Geriatrics, Internal Medicine, Oncology, Orthopedic surgery, Primary care medicine | Leave a comment

TV Quack Dr. David Agus still likes daily aspirin despite heart guidelines dropping it

March 23, 2019- Updated April 14, 2020 by Steven Greer Nobody has

Posted in - Pharma, Cardiology, CDC, FDA, Oncology | Comments Off on TV Quack Dr. David Agus still likes daily aspirin despite heart guidelines dropping it

The Breville blender is an essential tool for a meatless diet

November 12, 2019- by Steven E. Greer, MD

Posted in - Reviews, books, devices, Bariatric surgery, Cardiac surgery, Cardiology, Diabetes and endocrinology, FDA, Gastroenterology and liver, Internal Medicine, Neurology, Oncology, Pediatrics, Sports medicine | Comments Off on The Breville blender is an essential tool for a meatless diet

Trying Beyond Meat for the first time

November 12, 2019- by Steven E. Greer, MD

Posted in - Opinion, - Reviews, books, devices, Bariatric surgery, Cardiac surgery, Cardiology, Diabetes and endocrinology, FDA, Gastroenterology and liver, Internal Medicine, Neurology, Oncology, Pediatrics, Sports medicine, Vascular Surgery | Comments Off on Trying Beyond Meat for the first time

Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma

February 27, 2017- interviewed by Steven E. Greer, MD We interviewed Joaquim Bellmunt, MD, PhD, the Director of the Bladder Cancer Center at Dana-Farber,

Posted in - Biotech, - NEJM, - Pharma, Harvard, Oncology | Leave a comment

Paul Richardson, MD: Current Therapies for Multiple Myeloma

December 15, 2015- Interviewed by Steven Greer, MD Dr. Paul Richardson, Clinical Director of the Multiple Myeloma Center at Harvard’s Dana-Farber

Posted in - Biotech, - Pharma, Harvard, Oncology | Leave a comment

Go Vegan?

November 3, 2019- by Steven E. Greer, MD My diet is much better than it used to be. I eat a lot more plants and almost no red meat. I snack

Posted in - Opinion, - Reviews, books, devices, Bariatric surgery, Cardiac surgery, Cardiology, Diabetes and endocrinology, FDA, Gastroenterology and liver, Harvard, Internal Medicine, Oncology, Pediatrics, Sports medicine | Comments Off on Go Vegan?

BRAF and MEK combos for melanoma

Update October 1, 2015- The FDA approved the use of two drugs, Opdivo and Yervoy, to treat metastatic melanoma, as we first discussed with Dr.  Ribas last year.

Posted in - Biotech, - Pharma, Oncology, UCLA | Leave a comment

What is Justice Ruth Bader Ginsburg’s prognosis?

December 21, 2018- by Steven E. Greer, MD Supreme Court Justice Ruth Bader Ginsburd underwent surgery at Memorial Sloan Kettering

Posted in - Opinion, Cardiac surgery, Memorial Sloan-Kettering, Oncology | Leave a comment